This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Evaluation of the Impact of Embryo Biopsy on the Reproductive Potential of Embryos Undergoing In Vitro Fertilization (IVF)

Sponsored by Reproductive Medicine Associates of New Jersey

About this trial

Last updated 12 years ago

Study ID

RMA-00-17

Status

Completed

Type

Observational

Placebo

No

Accepting

18-75 Years
18 to 35 Years
All
All

Trial Timing

Ended 13 years ago

What is this trial about?

To assess the impact of embryo biopsy on the reproductive potential of human embryos.

What are the participation requirements?

Yes

Inclusion Criteria

This study will recruit patients from the NY/NJ/CT/eastern PA area only. 1. Maximum of one prior failed IVF treatment cycle 2. Female partner less than 35 years of age 3. Normal day 3 FSH level (<10 miu/mL) 4. Total basal antral follicle count greater than or equal to 12 5. Male partner with greater than 100,000 total motile spermatozoa and at least 1% normal forms 6. Body mass index (BMI) < or = 32 7. Normal uterine cavity

No

Exclusion Criteria

1. Diagnosis of chronic anovulation secondary to polycystic ovarian disease 2. Diagnosis of endometrial insufficiency 3. Clinical indication for pre-implantation genetic diagnosis (PGD) (undergoing IVF with PGD to rule out a known genetic defect) 4. Use of testicular aspiration or biopsy procedures to obtain sperm

Locations

Location

Status